UK finalises US pharma deal granting tariff-free access for British medicines - Reuters
UK finalises US pharma deal granting tariff-free access for British medicines Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"The partnership would support Britain’s world-leading pharmaceutical sector while protecting high-skilled jobs."
— Peter Kyle , Politician
"President Donald Trump is seeking to ensure that trading partners pay their 'fair share' for innovative medicines."
— Jamieson Greer , Executive
"the partnership would support Britain’s world-leading pharmaceutical sector while protecting high-skilled jobs."
— Peter Kyle , Politician
"President Donald Trump is seeking to ensure that trading partners pay their 'fair share' for innovative medicines."
— Jamieson Greer , Executive
Key People
Former president of the United States known for his aggressive economic policies.
Jamieson Greer is the U.S. Trade Representative.
British Prime Minister and leader of the Labour Party.
Business Secretary who advocates for backing British technology companies.
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQUTA4djBMVHlQMnJDLXMzbkx6OVQ3dzRyekE2OTNUUmVyQWFBMk5YZDJablJHZGI4OGZrM0poeV9CSkp4bDVWNGFxcGwxSml6SGpRMFV1U1d0bUx4Uy1oaXdFVVpDa2duemM4UmgzQ0FZdkV2ZnhQdjFPOE0yUllmemU5LURBRVkxS1VoenZOSjlvc1ltdkZYZklfdmx0LVVHb2l4WHAwUHZ1UHg5THBkTzk0enVGcTc0U0Nvbm9SN2NBcVZ4alMw?oc=5" target="_blank">UK finalises US pharma deal granting tariff-free access for British medicines</a> <font color="#6f6f6f">Reuters</font>
Britain has finalised a U.S.-UK pharmaceutical trade deal, setting out tariff-free access for UK-made medicines to the United States for at least three years.
The U.K. has officially secured zero tariffs on drug exports to the U.S., aiming to reattract biopharma investment by increasing NHS spending on new medicines by 25%.
Britain has agreed the full text of a U.S.-UK pharmaceutical partnership, setting out terms under which British-made medicines would enter the United States tariff-free.
Britain has agreed the full text of a U.S.-UK pharmaceutical partnership, setting out terms under which British-made medicines would enter the United States tariff-free.
The UK has secured a zero-tariff agreement on pharmaceutical exports to the US, marking a significant milestone in post-Brexit trade strategy and transatlantic economic alignment.
Similar Stories
Related coverage based on topic and tags
US raises pressure on EU to 'deliver' on non-tariff trade commitments - Reuters
US raises pressure on EU to 'deliver' on non-tariff trade commitments Reuters
August 14, 2026 at 05:24 PMBrazil opens reciprocity process against US over tariffs - Reuters
Brazil opens reciprocity process against US over tariffs Reuters
August 13, 2026 at 11:45 PMUS, Canada try to bridge gaps over potential autos tariff cuts, sources say - Reuters
US, Canada try to bridge gaps over potential autos tariff cuts, sources say Reuters
August 17, 2026 at 09:35 PMUS, Canada trade negotiators meet after Trump sets new tariff deadline - Reuters
US, Canada trade negotiators meet after Trump sets new tariff deadline Reuters
August 19, 2026 at 05:49 PMBritish data group Quantexa exploring UK or US IPO - Reuters
British data group Quantexa exploring UK or US IPO Reuters
August 18, 2026 at 05:12 PMCarney and Trump speak ahead of 50% US tariff deadline - Reuters
Carney and Trump speak ahead of 50% US tariff deadline Reuters
August 18, 2026 at 05:29 PM